BRIEF

on NanoViricides, Inc. (NASDAQ:NNVC)

NanoViricides to Present at MicroCap Conference 2025

Stock price chart of NanoViricides, Inc. (EBR:NNVC) showing fluctuations.

Today, NanoViricides, Inc. will present at the MicroCap Conference in Atlantic City, NJ. The event takes place at 11am at The Borgata Hotel and is open to the public. NanoViricides will discuss advancements in their broad-spectrum antiviral drug candidate, NV-387, designed for MPOX disease.

The company is advancing towards Phase II clinical trials for NV-387 in Africa, a region significantly impacted by MPOX. NV-387 targets viruses using a host-side feature, potentially offering breakthroughs for respiratory viral infections and pandemics like H5N1 Bird Flu and COVID-19.

In animal models, NV-387 surpasses current treatments such as oseltamivir and baloxavir. The company underscores the potential of their nanoviricide technology to address viral diseases, highlighting a market significantly exceeding $10 billion.

R. H.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all NanoViricides, Inc. news